UnitedHealth Group stock gets guidance lift as AI test widens

UnitedHealth Group raised its adjusted 2026 earnings outlook after reporting third-quarter results on October 13. The insurer now expects adjusted earnings of at least 20.50 US dollars per share, according to UnitedHealth Group's earnings release.

What changed in the third quarter

Third-quarter revenue reached 112.7 billion US dollars, while earnings from operations rose to 6.6 billion US dollars from 4.3 billion US dollars a year earlier. Adjusted earnings per share increased to 4.69 US dollars from 2.92 US dollars.

The medical care ratio improved to 88.4 percent from 89.9 percent in the prior-year quarter. UnitedHealth said the ratio reflected medical-cost management, pricing discipline, benefit-design changes and care-delivery improvements. The result also included 610 million US dollars of favorable prior-period reserve development related to 2026 dates of service, an important adjustment when assessing the underlying trend.

AI gains face cost pressure

Optum Insight continues to develop AI-enabled solutions aimed at streamlining clinical documentation and improving payment accuracy and speed. The unit generated 5.5 billion US dollars of third-quarter revenue and 1.3 billion US dollars of operating earnings, compared with 920 million US dollars a year earlier.

UnitedHealth Group stock traded at 366.70 euros on Lang & Schwarz at 16:33 CET on Thursday, November 5, 2026. Investors can follow the real-time quote of UnitedHealth Group stock.

Investors can place the insurer's outlook in the broader US market context through the S&P 500 market reports.

The next major test is whether UnitedHealth can convert pricing discipline, medical-cost control and AI investment into durable earnings progress. More news and analyses on UnitedHealth Group stock track that debate.